Common-Size Income Statement
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
Income statement item | Description | The company |
---|---|---|
Operating income (loss) | The net result for the period of deducting operating expenses from operating revenues. | Boston Scientific Corp. operating income (loss) as a percentage of net sales increased from 2020 to 2021 and from 2021 to 2022. |
Income (loss) before income taxes | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. | Boston Scientific Corp. income (loss) before income taxes as a percentage of net sales increased from 2020 to 2021 but then slightly decreased from 2021 to 2022. |
Net income (loss) | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. | Boston Scientific Corp. net income (loss) as a percentage of net sales increased from 2020 to 2021 but then slightly decreased from 2021 to 2022. |